A survey of population analysis methods and software for complex pharmacokinetic and pharmacodynamic models with examples

An overview is provided of the present population analysis methods and an assessment of which software packages are most appropriate for various PK/PD modeling problems. Four PK/PD example problems were solved using the programs NONMEM VI beta version, PDx-MCPEM, S-ADAPT, MONOLIX, and WinBUGS, informally assessed for reasonable accuracy and stability in analyzing these problems. Also, for each program we describe their general interface, ease of use, and abilities. We conclude with discussing which algorithms and software are most suitable for which types of PK/PD problems. NONMEM FO method is accurate and fast with 2-compartment models, if intra-individual and interindividual variances are small. The NONMEM FOCE method is slower than FO, but gives accurate population values regardless of size of intra- and interindividual errors. However, if data are very sparse, the NONMEM FOCE method can lead to inaccurate values, while the Laplace method can provide more accurate results. The exact EM methods (performed using S-ADAPT, PDx-MCPEM, and MONOLIX) have greater stability in analyzing complex PK/PD models, and can provide accurate results with sparse or rich data. MCPEM methods perform more slowly than NONMEM FOCE for simple models, but perform more quickly and stably than NONMEM FOCE for complex models. WinBUGS provides accurate assessments of the population parameters, standard errors and 95% confidence intervals for all examples. Like the MCPEM methods, WinBUGS's efficiency increases relative to NONMEM when solving the complex PK/PD models.

[1]  D. Bates,et al.  Newton-Raphson and EM Algorithms for Linear Mixed-Effects Models for Repeated-Measures Data , 1988 .

[2]  L Aarons,et al.  Software for Population Pharmacokinetics and Pharmacodynamics , 1999, Clinical pharmacokinetics.

[3]  Malcolm Rowland,et al.  Reducing Whole Body Physiologically Based Pharmacokinetic Models Using Global Sensitivity Analysis: Diazepam Case Study , 2006, Journal of Pharmacokinetics and Pharmacodynamics.

[4]  D J Roe Comparison of population pharmacokinetic modeling methods using simulated data: results from the Population Modeling Workgroup. , 1997, Statistics in medicine.

[5]  A. Joshi,et al.  Pharmacokinetic–Pharmacodynamic–Efficacy Analysis of Efalizumab in Patients with Moderate to Severe Psoriasis , 2005, Pharmaceutical Research.

[6]  E. Ette,et al.  Designing Cross-Sectional Population Pharmacokinetic Studies: Implications for Pediatric and Animal Studies , 1996 .

[7]  Goonaseelan Pillai,et al.  Non-Linear Mixed Effects Modeling – From Methodology and Software Development to Driving Implementation in Drug Development Science , 2005, Journal of Pharmacokinetics and Pharmacodynamics.

[8]  David J. Spiegelhalter,et al.  Introducing Markov chain Monte Carlo , 1995 .

[9]  F Mentré,et al.  Population kinetics and conditional assessment of the optimal dosage regimen using the P-PHARM software package. , 1994, Anticancer research.

[10]  Walter R. Gilks,et al.  Full conditional distributions , 1995 .

[11]  Leon Aarons The estimation of population pharmacokinetic parameters using an EM algorithm. , 1993, Computer methods and programs in biomedicine.

[12]  L. Skovgaard NONLINEAR MODELS FOR REPEATED MEASUREMENT DATA. , 1996 .

[13]  Ene I. Ette,et al.  Analysis of animal pharmacokinetic data: Performance of the one point per animal design , 1995, Journal of Pharmacokinetics and Biopharmaceutics.

[14]  Leon Aarons,et al.  Propagation of Population Pharmacokinetic Information Using a Bayesian Approach: Comparison with Meta-Analysis , 2005, Journal of Pharmacokinetics and Pharmacodynamics.

[15]  Stephen B Duffull,et al.  ANALYSIS OF POPULATION PHARMACOKINETIC DATA USING NONMEM AND WinBUGS , 2004, Journal of biopharmaceutical statistics.

[16]  Ivelina Gueorguieva,et al.  Diazepam Pharamacokinetics from Preclinical to Phase I Using a Bayesian Population Physiologically Based Pharmacokinetic Model with Informative Prior Distributions in Winbugs , 2006, Journal of Pharmacokinetics and Pharmacodynamics.

[17]  He Sun,et al.  Balanced Designs in Longitudinal Population Pharmacokinetic Studies , 1998, Journal of clinical pharmacology.

[18]  D. Bates,et al.  Approximations to the Log-Likelihood Function in the Nonlinear Mixed-Effects Model , 1995 .

[19]  David Z. D'Argenio,et al.  Model for Intracellular Lamivudine Metabolism in Peripheral Blood Mononuclear Cells Ex Vivo and in Human Immunodeficiency Virus Type 1-Infected Adolescents , 2006, Antimicrobial Agents and Chemotherapy.

[20]  David J. Spiegelhalter,et al.  Estimation of population pharmacokinetics using the Gibbs sampler , 1995, Journal of Pharmacokinetics and Biopharmaceutics.

[21]  Thomas M. Ludden,et al.  Estimation of Population Pharmacokinetic Parameters in the Presence of Non-compliance , 2003, Journal of Pharmacokinetics and Pharmacodynamics.

[22]  Lewis B. Sheiner,et al.  Evaluation of methods for estimating population pharmacokinetic parameters. I. Michaelis-menten model: Routine clinical pharmacokinetic data , 1980, Journal of Pharmacokinetics and Biopharmaceutics.

[23]  D. B. White,et al.  An evaluation of point and interval estimates in population pharmacokinetics using Nonmem analysis , 1991, Journal of Pharmacokinetics and Biopharmaceutics.

[24]  Jon Wakefield,et al.  Bayesian Analysis of Population PK/PD Models: General Concepts and Software , 2002, Journal of Pharmacokinetics and Pharmacodynamics.

[25]  F Mentré,et al.  Hyperparameter estimation using stochastic approximation with application to population pharmacokinetics. , 1988, Biometrics.

[26]  J F Boisvieux,et al.  Alternative approaches to estimation of population pharmacokinetic parameters: comparison with the nonlinear mixed-effect model. , 1984, Drug metabolism reviews.

[27]  R. Gomeni,et al.  A two-step iterative algorithm for estimation in nonlinear mixed-effect models with an evaluation in population pharmacokinetics. , 1995, Journal of biopharmaceutical statistics.

[28]  D. Bates,et al.  Nonlinear mixed effects models for repeated measures data. , 1990, Biometrics.

[29]  Stephen G Walker,et al.  AN EM ALGORITHM FOR NONLINEAR RANDOM EFFECTS MODELS , 1996 .

[30]  Davide Verotta,et al.  Pharmacokinetic–Pharmacodynamic Modelling: History and Perspectives , 2006, Journal of Pharmacokinetics and Pharmacodynamics.

[31]  Siv Jönsson,et al.  Estimating Bias in Population Parameters for Some Models for Repeated Measures Ordinal Data Using NONMEM and NLMIXED , 2004, Journal of Pharmacokinetics and Pharmacodynamics.

[32]  Robert J. Bauer,et al.  Monte Carlo Parametric Expectation Maximization (MC-PEM) Method for Analyzing Population Pharmacokinetic/Pharmacodynamic Data , 2004 .

[33]  L B Sheiner,et al.  Estimating population kinetics. , 1982, Critical reviews in biomedical engineering.